Showing results (21-30 of 162) with videos related to
Sort By:
Pageof 17
Cancer Research|December 1, 1989
Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cellsD S Shewach, B S MitchellMolecular Pharmacology|September 1, 1992
Nucleotide specificity of human deoxycytidine kinaseD S Shewach, K K Reynolds, L HertelCancer Research|April 5, 2000
Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyureaP D Boucher, L J Ostruszka, D S ShewachCancer Research|September 10, 1998
Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killingL Z Rubsam, B L Davidson, D S ShewachHuman Gene Therapy|May 15, 1998
Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinaseP D Boucher, R J Ruch, D S ShewachBiochemical Pharmacology|April 6, 1993
Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinaseD S Shewach, D C Liotta, R F SchinaziBiochemical Pharmacology|April 1, 1992
Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell lineD S Shewach, J Ellero, W R Mancini, et al.Cancer Research|May 1, 1992
Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase geneJ K Owens, D S Shewach, B Ullman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Inhibition of fludarabine metabolism by arabinosylcytosine during therapyA Kemena, V Gandhi, D S Shewach, et al.Cancer Gene Therapy|August 27, 2011
Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovirB Ladd, J J O'Konek, L J Ostruszka, et al.Pageof 17